Biggest News Aggregation in the World
๐Ÿ“ฐ Nasdaq Bbio News

Page 2 - Nasdaq Bbio News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nasdaq Bbio. Real-time updates on events, politics, business and more.

Blueshift Asset Management LLC Takes Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO)

Blueshift Asset Management LLC purchased a new position in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 16,482 shares of the company’s stock, valued at approximately $435,000. Several other large investors have also recently made changes to […]
Bridgebio Pharma Bio Pharma Frank Mccormick Hannah Valantine Emerald Advisers Moody Aldrich Partners
Source: wkrb13.com

BridgeBio Pharma (NASDAQ:BBIO) Coverage Initiated by Analysts at BMO Capital Markets

BMO Capital Markets assumed coverage on shares of BridgeBio Pharma (NASDAQ:BBIO – Free Report) in a research note published on Wednesday morning, MarketBeat reports. The firm issued a market perform rating and a $37.00 price objective on the stock. A number of other brokerages also recently issued reports on BBIO. Citigroup assumed coverage on BridgeBio […]
Hannah Valantine Bio Pharma Frank Mccormick Bridgebio Pharma Bridgebio Pharma Company Profile Assetmark Inc
Source: wkrb13.com

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives Consensus Rating of "Moderate Buy" from Brokerages

Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating on the company. The average 1 […]
Randalw Scott Bridgebio Pharma Bio Pharma Frank Mccormick Bridgebio Pharma Company Profile Topco Ltd

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Financial Contrast: Equillium (NASDAQ:EQ) versus BridgeBio Pharma (NASDAQ:BBIO)

BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) and Equillium (NASDAQ:EQ – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, valuation, profitability, institutional ownership, risk and analyst recommendations. Institutional & Insider Ownership 90.9% of BridgeBio Pharma shares […]
United States La Jolla Palo Alto Bio Pharma Bridgebio Pharma Leidos Biomedical Research Inc

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives $40.23 Consensus Target Price from Analysts

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) has received an average rating of “Moderate Buy” from the thirteen analysts that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and twelve have given a buy recommendation to the company. The average 12 month price objective among […]
Randalw Scott Bridgebio Pharma Bio Pharma Frank Mccormick China Universal Asset Management Co Wells Fargo Company

Insider Selling: BridgeBio Pharma, Inc. (NASDAQ:BBIO) Director Sells 2,000 Shares of Stock

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) Director Randal W. Scott sold 2,000 shares of BridgeBio Pharma stock in a transaction dated Monday, December 18th. The shares were sold at an average price of $40.00, for a total value of $80,000.00. Following the completion of the transaction, the director now owns 9,000 shares of […]
Randalw Scott Bio Pharma Bridgebio Pharma Inc Cantor Fitzgerald Covestor Ltd Bridgebio Pharma Company Profile

BridgeBio Pharma (NASDAQ:BBIO) Hits New 1-Year High at $37.03

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) hit a new 52-week high during mid-day trading on Friday . The company traded as high as $37.03 and last traded at $36.34, with a volume of 530472 shares traded. The stock had previously closed at $35.91. Analyst Upgrades and Downgrades BBIO has been the topic of […]
New Zealand General New Zealand Bio Pharma Principal Financial Group Inc Cantor Fitzgerald Bridgebio Pharma Company Profile

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Average Rating of "Moderate Buy" by Brokerages

Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) have received a consensus rating of “Moderate Buy” from the thirteen analysts that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. The average […]
New Zealand General New Zealand Bio Pharma Bridgebio Pharma Jpmorgan Chase Co Bridgebio Pharma Company Profile

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science